Ju Bai

发表

Management of cytokine release syndrome related to CAR-T cell therapy

B. Lei, Wanggang Zhang, Liu-fang Gu, 2019, Frontiers of Medicine.

Expression, regulation and function of miR-495 in healthy and tumor tissues.

A. He, Hongli Chen, Ju Bai, 2017, Oncology letters.

Expression profile analysis of long non‐coding RNA in acute myeloid leukemia by microarray and bioinformatics

Tian Liu, Liu-fang Gu, Fangxia Wang, 2018, Cancer science.

Detection of serum tumor markers in multiple myeloma using the CLINPROT system

Juan Yang, Wanggang Zhang, A. He, 2012, International Journal of Hematology.

Using Circ-ANAPC7 as a Novel Type of Biomarker in the Monitoring of Acute Myeloid Leukemia

A. He, Yun Yang, Hongli Chen, 2019, Acta Haematologica.

Prediction and identification of HLA-A*0201-restricted epitopes from leukemia-associated protein MLAA-22 which elicit cytotoxic T lymphocytes

Wanggang Zhang, Jing Li, Liu-fang Gu, 2014, Medical Oncology.

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2018, Medicina Clínica (English Edition).

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia.

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2017, Medicina clinica.

Serum platelet factor 4 is a promising predictor in newly diagnosed patients with multiple myeloma treated with thalidomide and VAD regimens

Wanggang Zhang, Fangxia Wang, A. He, 2019, Hematology.

The anti-apoptosis effect of MLAA-34 in leukemia and the β-catenin/T cell factor 4 protein pathway.

B. Lei, Wanggang Zhang, Xiu-lian Wang, 2015, American journal of translational research.

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Saijuan Chen, Hua Jiang, Jian-yong Li, 2022, Journal of Hematology & Oncology.

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

B. Lei, Y. Geng, Zong-fang Li, 2018, Journal of Hematology & Oncology.

Focusing on long non‐coding RNA dysregulation in newly diagnosed multiple myeloma

Yan Peng, Fangxia Wang, A. He, 2018, Life sciences.

Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma

Jinsong Hu, Fangxia Wang, A. He, 2020, Cell Stress and Chaperones.

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Juan Yang, Wanggang Zhang, A. He, 2013, Proteome Science.

Busulfan plus fludarabine compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplantation in patients with hematologic neoplasms: a meta-analysis.

Fangxia Wang, A. He, Hongli Chen, 2015, International journal of clinical and experimental medicine.

Horse versus rabbit antithymocyte globulin in immunosuppressive therapy of treatment-naïve aplastic anemia: a systematic review and meta-analysis

Huan Yao, Wanggang Zhang, Xiao-rong Ma, 2017, Annals of Hematology.

Identification of HLA-A*0201-restricted CTL Epitopes for MLAA-34-specific Immunotherapy for Acute Monocytic Leukemia

Wanggang Zhang, Fangxia Wang, A. He, 2021, Journal of immunotherapy.

Circ-ANAPC7 is Upregulated in Acute Myeloid Leukemia and Appears to Target the MiR-181 Family

Yuqiang Ji, Tian Liu, Juan Yang, 2018, Cellular Physiology and Biochemistry.

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Zong-fang Li, B. Lei, Y. Geng, 2018, Blood.

miR‐582‐5p serves as an antioncogenic biomarker in intermediate risk AML with normal cytogenetics and could inhibit proliferation and induce apoptosis of leukemia cells

Fangxia Wang, A. He, Hongli Chen, 2020, Cell biology international.

Comprehensive Analysis of m6A RNA Methylation Regulators in the Prognosis and Immune Microenvironment of Multiple Myeloma

R. Liu, Jinsong Hu, A. He, 2021, Frontiers in Oncology.

Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Fangxia Wang, A. He, Yun Yang, 2019, Clinical Proteomics.

Anti-Tumour and Immune Enhancing Activities of MLAA-22379–387 on Acute Myeloid Leukemia

Wanggang Zhang, Y. Geng, Jing Li, 2020, Current Science.

Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling

Yang Zhang, Juan Yang, Wanggang Zhang, 2013, Proteome Science.

Serum peptidome based biomarkers searching for monitoring minimal residual disease in adult acute lymphocytic leukemia

Yang Zhang, Juan Yang, Wanggang Zhang, 2014, Proteome Science.

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

B. Lei, Y. Geng, Zong-fang Li, 2019, Blood.

Role of mTOR signaling pathway in acute myeloid leukemia

A. He, Ju Bai, Ying Shen, 2016 .

Blockade of HSP70 by VER-155008 synergistically enhances bortezomib-induced cytotoxicity in multiple myeloma

Fangxia Wang, A. He, Yun Yang, 2020, Cell Stress and Chaperones.

Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Fangxia Wang, A. He, Yun Yang, 2019, Clinical Proteomics.

High Expression Levels of Long Noncoding RNA Small Nucleolar RNA Host Gene 18 and Semaphorin 5A Indicate Poor Prognosis in Multiple Myeloma

Yanping Ma, Jinsong Hu, Fangxia Wang, 2019, Acta Haematologica.

Deregulated Expression of Long Non-Coding RNA AC092580.4 in Acute Myeloid Leukemia

Fangxia Wang, A. He, Baiyan Wang, 2018, Blood.

MicroRNA: an important regulator in acute myeloid leukemia

A. He, Hongli Chen, Ju Bai, 2017, Cell biology international.

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Liu-fang Gu, Fangxia Wang, Xing-mei Cao, 2022, Journal of Medical Case Reports.

Fangxia Wang, A. He, Hongli Chen, 2015, International journal of clinical and experimental medicine.

Risk score constructed with neutrophil extracellular traps-related genes predicts prognosis and immune microenvironment in multiple myeloma

Ju Bai, Dandan Gao, Aili He, 2024, Frontiers in oncology.